Company profile

Circle Cardiovascular Imaging

Cardiology & Cardiovascular Health

Company profile

About Circle Cardiovascular Imaging

Circle Cardiovascular Imaging (Circle CVI) is a Canadian-based medical imaging software company founded in 2007 that has become a globally recognized leader in cardiovascular imaging analysis. The company develops innovative AI-powered software solutions designed to enhance cardiovascular imaging analysis and improve patient care across cardiac and neurological applications. Circle's flagship platform, cvi42, provides comprehensive tools for cardiac MR, cardiac CT, vascular CT, interventional planning, and electrophysiology, serving as an all-encompassing cardiac imaging solution. The platform features automated workflows powered by AI trained on large datasets and various pathological patterns, enabling accurate diagnosis, improved patient throughput, and enhanced reproducibility. In 2024, Circle launched its next generation of products centered on accessibility, interoperability, and efficiency. The company also offers StrokeSENS, an AI-based solution for early identification of acute stroke that aids front-line physicians in timely patient management decisions. With over 600 installations worldwide across more than 100 countries, Circle serves leading healthcare institutions globally, including top hospitals that rely on its technology for both clinical and research purposes. The company maintains strong partnerships with major medical imaging OEMs including GE Healthcare and Siemens Healthineers, offering integrated deployment options on their workstation platforms. Circle's solutions seamlessly integrate with existing clinical workflows and systems, featuring streamlined reporting capabilities that reduce clerical workload and improve patient outcomes. The company has earned industry-leading customer satisfaction scores and maintains a reputation for exceptional customer service and continuous innovation in the cardiovascular imaging field.

Company description Circle Cardiovascular Imaging official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Circle Cardiovascular Imaging?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Acute stroke
  • Cardiac pathologies
  • Coronary artery disease
  • Electrophysiology conditions
  • Structural heart conditions
  • Vascular disease

Who it serves

  • Academic medical centers
  • Cardiac imaging centers
  • Health Systems
  • Hospitals
  • Research institutions

Deployment & integration

Embedded · Hybrid deployment with recorded integration context.

Recorded integration context: GE FastStroke, GE Healthcare AW Server, GE Healthcare AW workstation, Siemens Healthineers syngo.via.

Geographic context

Markets600+ installations globally · Global - sold in over 100 countries · Used by top hospitals worldwide
Company sourceOfficial website

Company milestones

Platform expansion

2024 marked the launch of next generation of products centered around accessibility, interoperability, and efficiency. cvi42 version 6.4 released.

Partnerships

Recorded partners

  • GE Healthcare
  • Siemens Healthineers

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Vascular Solutions

AI-enabled platform for vascular assessment

Software · HybridCompany source

cvi42

One Platform for All Your Advanced Cardiac Imaging Needs

Software · HybridCompany source

cvi42 Cardiac CT

Dedicated tools for comprehensive assessment of coronary artery disease

Software · HybridCompany source

cvi42 Cardiac MR

Market-leading solution for all clinical and research cardiac MR needs

Software · HybridCompany source

cvi42 Electrophysiology

Pre-procedural planning tools for electrophysiologists

Software · HybridCompany source

cvi42 Interventional Planning

Fast and effective planning for structural heart interventions

Software · HybridCompany source

report42

Streamlined reporting system for cardiovascular imaging

Software · HybridCompany source

StrokeSENS

AI-based identification of acute stroke pathology for faster clinical decisions

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Validation of an Automated ASPECTS Software via a Multi-Reader Multi-Case Clinical Reader Study.

AJNR. American journal of neuroradiology · Jun 29, 2026

Reference ranges for myocardial native T1, T2, and extracellular volume at 5.0T cardiac magnetic resonance imaging in healthy adults.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · Jun 4, 2026

Prognosis and risk stratification in first-presentation myocardial infarction with nonobstructive coronary arteries using stress cardiac MRI.

Insights into imaging · May 29, 2026

Comparing prognostic significance of dual bolus and dual sequence quantitative stress perfusion cardiac magnetic resonance.

European heart journal. Cardiovascular Imaging · Feb 27, 2026

Late gadolinium enhancement in patients with and without autoimmune rheumatic diseases: "walking, we create the way".

European journal of radiology · Feb 1, 2026

Lateralized cerebral arterial blood flow and blood pressure adaptations to short-term head-down tilt: a 4D flow MRI study with cognitive function assessment.

Military Medical Research · Jan 1, 2026

Clinical validation

Clinical-trial records

Effects of DHEA in Pulmonary Hypertension

NCT03648385 · Mentioned · COMPLETED

Prognostic Role of LA Strain in Acute Myocardial Infarction

NCT06408636 · Mentioned · COMPLETED

Regulatory

Regulatory records

cvi42 Coronary Plaque Software Application

K251027 · 510k · Oct 27, 2025

StrokeSENS ASPECTS Software Application

K250221 · 510k · Jul 1, 2025

cvi42 Software Application

K242781 · 510k · Oct 15, 2024

Cardiac CT Function Software Application

K241038 · 510k · Jun 7, 2024

Myocardial Strain Software Application

K232661 · 510k · Dec 7, 2023

TruPlan Computed Tomography (CT) Imaging Software

K222593 · 510k · Jan 18, 2023

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Improved patient throughput

Automated workflows and streamlined reporting

Increased accuracy and reproducibility

AI-based imaging technology

Reduced backlogs

Automated workflows increase time for patient care

Industry-leading customer satisfaction

Net Promoter Score (NPS) and Customer Satisfaction (CSAT)

Barts Heart Centre, Queen Mary University of London

High-volume CMR service delivery with over 12 consultants and multiple trainees

Would not be able to deliver high-volume CMR service without cvi42 and report42, used clinically for approximately 4 years after 10 years of research use

Jose Michel Kalaf Research Institute, Radiologia Clinica de Campinas

CMR imaging for clinical and research purposes since 2008, shaping workflow practices

Software maintained core simplicity while delivering technological advancements over a decade, enabling productive workflow

Minneapolis Heart Institute, Abbott Northwestern Hospital

Clinical practice for cardiac MRI and CT post-processing analysis with improved communication of findings

Described as invaluable to clinical practice with intuitive analysis for both clinical and research purposes

National Heart Centre Singapore

High-volume tertiary cardiac center delivering high-quality imaging reports with seamless post-processing across scanning platforms, supporting clinical service, CMR training, and research studies

Enables delivery of high-volume CMR service with reasonable turn-around time across multiple consultants and trainees

Paris Saint-Joseph Hospital

Routine clinical studies and advanced research with multi-vendor capabilities, pathology tagging for education and multi-centric study review

Faster read time per patient with comprehensive tools for simple and complex studies, recognized as reference for CMR imaging

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Erkan Akyuz

Chief Executive Officer

LinkedIn

Mike Little

Chief Financial Officer

Scott Galbari

Chief Product Officer

LinkedIn

Christian Bazinet

Chief Revenue Officer

06 · Company updates

Updates from Circle Cardiovascular Imaging

Recent articles published on Circle Cardiovascular Imaging's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon